Seeking for biological markers in suicidal behaviour;Á procura de marcadores biológicos no comportamento suicidário

Acta Medica Portuguesa

Volumn 21, Issue 1-3, 2008, Pages 89-98

  Arantes Gonçalves, Filipe ^a   Coelho, Rui ^a  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN MONOAMINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEXAMETHASONE; ENDOCANNABINOID; MONOAMINE; NEUROTROPHIN 3; OPIATE RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; THYROID HORMONE; TRYPTOPHAN HYDROXYLASE; SEROTONIN;

DOPAMINERGIC SYSTEM; GENETIC POLYMORPHISM; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LIPID METABOLISM; NEUROTRANSMISSION; NORADRENERGIC SYSTEM; REVIEW; SEROTONIN METABOLISM; SEROTONINERGIC SYSTEM; SUICIDAL BEHAVIOR; PHYSIOLOGY; SUICIDE;

BIOLOGICAL MARKERS; HUMANS; RECEPTORS, SEROTONIN; SEROTONIN; SUICIDE;

EID: 51349104927     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. MANN JJ: Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003;4(10):819-828
2. SULLIVAN GM, OQUENDO MA, HUANG YY, MANN JJ: Elevated cerebrospinal fluid 5-hydroxyindolacetic acid levels in women with co morbid depression and panic disorder. Int J Neuropsychopharmacol 2006;9(5):547-556
3. JOINER TE JR, BROWN JS, WINGATE LR: The psychology and neurobiology of suicidal behaviour. Annu Rev Psychol 2005;56:287-314
4. OQUENDO MA, CURRIER D, MANN JJ: Prospective studies of suicidal behaviour in major depression and bipolar disorders: what is the evidence for predictive risk factors? Acta Psychiatr Scand 2006;114(3):151-8
5. KAMALI, M. OQUENDO, MA. MANN JJ: Understanding the neurobiology of suicidal behaviour. Depress Anxiety 2001;14(3):164-176
6. MANN JJ, STOFF DM: A synthesis of current findings regarding neurobiological correlates and treatment of suicidal behaviour. Ann N Y Acad Sci 1997;836:352-363
7. SHER L, OQUENDO MA, GRUNEBAUM MF, BURKE AK, HUANG YY, MANN JJ: CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence. Eur Neuropsychopharmacol 2007;17(1):12-5
8. Sublett ME, Oquendo MA, Mann JJ: Rational approaches to the neurobiologic study of youth at risk for bipolar disorder and suicide. Bipolar Disord 2006;8:526-42
9. LOPEZ JF, VAZQUEZ DM, CHALMERS DT, WATSON SJ: Regulation of 5-HT receptors and the hypothalamic-pituitary-adrenal axis. Implications for the neurobiology of suicide. Ann N Y Acad Sci 1997;836:106-134
10. MANN JJ, CURRIER D, STANLEY B, OQUENDO MA, AMSEL LV, ELLIS SP: Can biological tests assist prediction of suicide in mood disorders? Int J Neuropsychopharamacol 2006;9(4):465-474
11. HARKAVY-FRIEDMAN JM, KEILP JG, GRUNEBAUM MF et al: Are BPI and BPII suicide attempters distinct neuropsychologically? J Affect Disord 2006;94(1-3):255-9
12. BRONISCH T, BRUNNER J, BONDY B. Rujescu, D. Bishof, G. Heuser, I. et al. A multicenter study about Neurobiology of Suicidal Behaviour: design, development and preliminary results. Arch Suicide Res 2005;9(1):19-26
13. HEERINGEN KV: The neurobiology of suicide and suicidality. Can J Psychiatry 2003;48(5):292-300
14. OQUENDO MA, RUSSO SA, UNDERWOOD MD et al: Higher Postmortem Prefrontal 5-HT2a Receptor Binding Correlates with Lifetime Aggression in Suicide. Biol Psychiatry 2006;59:235-243
15. UNDERWOOD MD, MANN JJ, ARANGO V: Serotoninergic and noradrenergic neurobiology of alcoholic suicide. Alcohol Clin Exp Res 2004;28:57S-69S
16. MANN JJ, BRENT DA, ARANGO V: The neurobiology and genetics of suicide and attemptes suicide: a focus on the serotoninergic system. Neuropsychopharmacol 2001;24(5):467-477
17. SHER L: On the role of neurobiological and genetic factors in the etiology and pathogenesis of suicidal behaviour among immigrants. Medical Hypothesis 1999;53(2):110-1
18. STOCKMEIER CA: Neurobiology of serotonin in depression and suicide. Ann N Y Acad Sci 1997;836:220-232
19. PANDEY GN: Altered serotonin function in suicide. Evidence from platelets and neuroendocrine studies. Ann N Y Acad Sci 1997;836:182-200
20. KAREGE F, PERROUD N, BURKHARDT S, SCHWALD M, BALLMANN E, LA HARPE R: Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims. Biol Psychiatry 2007;61:240-5
21. YOUNG LT, BEZCHLIBNYK YB, CHEN B, WANG JF, MACQUEEN GM: Amygdala cyclic adenosine monophosphate response element binding protein phosphorylation in patients with mood disorders: effects of diagnosis, suicide and drug treatment. Biol Psychiatry 2004;55(6):570-7
22. KAREGE F, VAUDAN G, SCHWALD M, PERROUD N, LA HARPE R: Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 2005;136(1-2):29-37
23. ARANTES-GONÇALVES F, COELHO R: Depression and Treatment. Apoptosis, Neuroplasticity and Antidepressants. Acta Med Port 2006;19:9-20
24. SUBLETTE ME, HIBBELN JR, GALFALBY H, OQUENDO MA, MANN JJ: Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am J Psychiatry 2006;163(6):1100-2
25. MARCINKO D, PIVAC N, MARTINAC M, JAKOVLJEVIC M, MIHALJEVIC-PELES A, MUCK-SELER D: Platelet serotonin and serum cholesterol concentrations in suicidal and nonsuicidal male patients with a first episode of psychosis. Psychiatry Res 2007;150(1):105-8
26. BOLDRINI M, UNDERWOOD MD, MANN JJ, ARANGO V: More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides. Brain Res 2005;1041(1):19-28
27. BAUMANN B, DANOS P, DIEKMANN S et al: Tyrosine hydroxylase immunoreactivity in the locus coeruleus is reduced in depressed non-suicidal patients but normal in depressed suicidal patientes. Eur Arch Psychiatry Clin Neurosci 1999;249(4):212-9
28. SEQUEIRA A, GWADRY FG, FFRENCH-MULLEN JM et al: Împlication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry 2006;63(1):35-48
29. GWADRY FG, SEQUEIRA A, JARLATH MH, FFRENCH-MULLEN JM, TURECKI G: Molecular characterization of suicide by micro array analysis. Am J Med Genet C Semin Med Genet 2005;133(1):48-56
30. TURECKI G, ZHU Z, TZENOVA J et al: TPH and suicidal behaviour: a study in suicide completers. Mol Psychiatry 2001;6(1):98-102
31. KLEMPAN T, TURECKI G: Suicide: a neurobiological point of view. Rev Bras Psiquiatr 2005;27(3):172-3
32. SHER L, MANN JJ, TRASKMAN-BENDZ L et al: Lower cerebrospinal fluid homovanillic acid levels in depressed suicide attempters. J Affect Disord 2006;90:83-9
33. ROY A, DE YONG J, LINNOILA M: Cerebrospinal fluid monoamine metabolites and suicidal behaviour in depressed patients. Arch Gen Psychiatry 1989;46:609-612
34. HUNGUND BL, VINOD KY, KASSIR SA et al: Upregulation of CB1 receptors and agonist-stimulated (35S) GTPgammaS binding in the prefrontal cortex of depressed suicide victims. Mol Psychiatry 2004;9(2):184-190
35. VINOD KY, HUNGUND BL: Role of the endocannabinoid system in depression and suicide. Trends Pharmacol Sci 2006;27(10):539-545
36. VINOD, KY. ARANGO, V. XIE, S et al: Elevated levels of endocannabinoids and CB1 receptor mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims. Biol Psychiatry 2005;57(5):480-6
37. STEINER, J. BIELAU, H. BRISCH R et al: Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatry Res 2006;14:1-7
38. SULLIVAN GM, MANN, JJ, OQUENDO MA, LO ES, COOPER TB, GORMAN JM: Low cerebrospinal fluid transthyretin levels in depression: correlations with suicidal ideation and low serotonin function. Biol Psychiatry 2006;60(5):500-6
39. ZALSMAN G, MOLCHO A, HUANG Y, DWORK A, LI S, MANN JJ: Postmortem mu-opioid receptor binding in suicide victims and controls. J Neural Transm 2005;112(7):949-954
40. OQUENDO MA, MANN JJ: Intervention research for suicidal behaviour. Lancet 2003;362:844-5